# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000950170-22-024727
Filing Date
2022-11-14
Accepted
2022-11-14 08:21:08
Documents
47
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | prld-20221114.htm iXBRL | 8-K | 71389
2 | EX-99.1 | prld-ex99_1.htm | EX-99.1 | 268369
3 | EX-99.2 | prld-ex99_2.htm | EX-99.2 | 26307
4 | GRAPHIC | img268059179_0.jpg | GRAPHIC | 9445
5 | GRAPHIC | prld-ex99_2s1.jpg | GRAPHIC | 75112
6 | GRAPHIC | prld-ex99_2s2.jpg | GRAPHIC | 125088
7 | GRAPHIC | prld-ex99_2s3.jpg | GRAPHIC | 62469
8 | GRAPHIC | prld-ex99_2s4.jpg | GRAPHIC | 57269
9 | GRAPHIC | prld-ex99_2s5.jpg | GRAPHIC | 67319
10 | GRAPHIC | prld-ex99_2s6.jpg | GRAPHIC | 43127
11 | GRAPHIC | prld-ex99_2s7.jpg | GRAPHIC | 67593
12 | GRAPHIC | prld-ex99_2s8.jpg | GRAPHIC | 55416
13 | GRAPHIC | prld-ex99_2s9.jpg | GRAPHIC | 70270
14 | GRAPHIC | prld-ex99_2s10.jpg | GRAPHIC | 66055
15 | GRAPHIC | prld-ex99_2s11.jpg | GRAPHIC | 67496
16 | GRAPHIC | prld-ex99_2s12.jpg | GRAPHIC | 63563
17 | GRAPHIC | prld-ex99_2s13.jpg | GRAPHIC | 65898
18 | GRAPHIC | prld-ex99_2s14.jpg | GRAPHIC | 66787
19 | GRAPHIC | prld-ex99_2s15.jpg | GRAPHIC | 68726
20 | GRAPHIC | prld-ex99_2s16.jpg | GRAPHIC | 56616
21 | GRAPHIC | prld-ex99_2s17.jpg | GRAPHIC | 63263
22 | GRAPHIC | prld-ex99_2s18.jpg | GRAPHIC | 68599
23 | GRAPHIC | prld-ex99_2s19.jpg | GRAPHIC | 63386
24 | GRAPHIC | prld-ex99_2s20.jpg | GRAPHIC | 69786
25 | GRAPHIC | prld-ex99_2s21.jpg | GRAPHIC | 46792
26 | GRAPHIC | prld-ex99_2s22.jpg | GRAPHIC | 72188
27 | GRAPHIC | prld-ex99_2s23.jpg | GRAPHIC | 50460
28 | GRAPHIC | prld-ex99_2s24.jpg | GRAPHIC | 77860
29 | GRAPHIC | prld-ex99_2s25.jpg | GRAPHIC | 55684
30 | GRAPHIC | prld-ex99_2s26.jpg | GRAPHIC | 63886
31 | GRAPHIC | prld-ex99_2s27.jpg | GRAPHIC | 64882
32 | GRAPHIC | prld-ex99_2s28.jpg | GRAPHIC | 43151
33 | GRAPHIC | prld-ex99_2s29.jpg | GRAPHIC | 48082
34 | GRAPHIC | prld-ex99_2s30.jpg | GRAPHIC | 62598
35 | GRAPHIC | prld-ex99_2s31.jpg | GRAPHIC | 54606
36 | GRAPHIC | prld-ex99_2s32.jpg | GRAPHIC | 92804
| Complete submission text file | 0000950170-22-024727.txt |  | 3395282

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
37 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | prld-20221114_lab.xml | EX-101.LAB | 17736
38 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | prld-20221114_pre.xml | EX-101.PRE | 11053
39 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | prld-20221114.xsd | EX-101.SCH | 2465
41 | EXTRACTED XBRL INSTANCE DOCUMENT | prld-20221114_htm.xml | XML | 4708

Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39527 | Film No.: 221380550
SIC: 2834 Pharmaceutical Preparations